Endoscopic retrograde cholangiopancreatography (ERCP) is an invasive endoscopic technique that has many diagnostic and therapeutic implications. It is a procedure with small but significant life-threatening complications. To ensure the best possible care, minimize complications, and improve the quality of health care, a constant review of the performance of the operator using ideal benchmark standards is needed. Hence, quality indicators are necessary. The American and European Societies of Gastrointestinal Endoscopy have provided guidelines on quality measures for ERCP, which describe the skills to be developed and training to be implemented in performing quality ERCP. These guidelines have divided the indicators into pre-procedure, intraprocedural, and post-procedure measures. The focus of this article was to review the quality indicators of ERCP.
Citations
Citations to this article as recorded by
Endoscopic retrograde cholangiopancreatography training conditions, results from a pan‐European survey: Between vision and reality Karim Hamesch, Oscar Cahyadi, Stavros Dimitriadis, Marcus Hollenbach, Pilar Acedo, Myriam Ayari, Helena Dauvarte, Egle Dieninyte, Viktor Domislovic, Ana Dugic, Martin Ďuriček, Omar Elshaarawy, Anne Fennessy, Mark Enrik Geissler, Zornitsa Gorcheva, Amer Ha United European Gastroenterology Journal.2025; 13(3): 474. CrossRef
Endoscopic retrograde cholangiopancreatography training using a silicone simulator fabricated using a 3D printing technique (with videos) Suk Pyo Shin, Kyong Joo Lee, Min Je Sung, Jong Chan Kim, Guk Bae Kim, Moo Yeop Kim, Sung Yong Han, Sung Ill Jang, Mamoru Takenaka, Chang-Il Kwon Scientific Reports.2025;[Epub] CrossRef
How to measure quality in ERCP? Franco Ana Rita, Arvanitakis Marianna, Teles de Campos Sara Best Practice & Research Clinical Gastroenterology.2025; 76: 101999. CrossRef
Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with intended primary metal stent for malignant distal biliary obstruction: a European prospective controlled multicentre trial (PUMa trial) D Schmitz, J B Gornals, J J Vila, A Schmidt, T Kleemann, J R Aparicio, A Amanzada, M Dollhopf, E Redondo-Cerezo, J Weigt, T Voigtländer, T von Hahn, J Rudi, C V Tortosa, A Küllmer, M Perez-Miranda Endoscopy.2025; 57(S 02): S6. CrossRef
Development of a Checklist for Evaluating Pancreatobiliary Endoscopy Training Facilities and Educational Programs Hyung Ku Chon, Sung-Jo Bang, Eaum Seok Lee, Tae Ju Jeon, Chang Hwan Park The Korean Journal of Pancreas and Biliary Tract.2025; 30(2): 93. CrossRef
Advancements in Research on Challenges in Selective Biliary Cannulation during Endoscopic Retrograde Cholangiopancreatography (ERCP) 天雨 张 Journal of Clinical Personalized Medicine.2024; 03(01): 100. CrossRef
Development of an Automated Endoscopic Retrograde Cholangiopancreatography Quality Report Card Using an Integrated Analytics Suite Anmol Singh, Eric Swei, Celestina Tolosa, Matthew Alverson, Todd A. Brenner, Avleen Kaur, Aida Metri, Mohammed Rifat Shaik, Nikhil Bush, Branislav Bujnak, Alexandra T. Strauss, Mouen Khashab, Eun Ji Shin, Vikesh K. Singh, Venkata S. Akshintala Techniques and Innovations in Gastrointestinal Endoscopy.2024; 26(3): 230. CrossRef
Validity of a virtual reality endoscopic retrograde cholangiopancreatography simulator: can it distinguish experts from novices? Konstantinos Georgiou, Nikola Boyanov, Pantelis Antonakis, Dimitrios Thanasas, Gabriel Sandblom, Lars Enochsson Frontiers in Surgery.2023;[Epub] CrossRef
Background /Aims: Diagnosis of Helicobacter pylori-naïve gastric cancer (HPNGC) is becoming increasingly important. This study aimed to explore the quality indicators for HPNGC detection.
Methods We conducted a cross-sectional, nationwide, web-based survey of gastrointestinal endoscopists in Japan. In addition to questions about the number of HPNGC cases detected in a year and basic information, the questionnaire also consisted of 28 questions: (1) 18 about HPNGC awareness, (2) six about diagnostic proactiveness, and (3) four about interest in HPNGC.
Results Valid responses were obtained from 712 endoscopists. The Japan Gastroenterological Endoscopy Society-certified endoscopists had a significantly higher HPNGC detection rate than the nonspecialists (0.42% vs. 0.32%, respectively; p=0.008). The results of the multiple regression analysis showed that Japan Gastroenterological Endoscopy Society certification and high awareness and interest scores were independent predictors of the HPNGC detection rate (p=0.012, p<0.001, p=0.024, respectively). Principal component analysis showed that the endoscopists who attended conferences for collecting information on HPNGC had a higher level of awareness.
Conclusions To improve the detection of HPNGC, it is necessary to increase the awareness of the disease. It is hoped that relevant societies will play an important role in endoscopists’ education.
Citations
Citations to this article as recorded by
Visibility evaluation of gastric epithelial neoplasm of fundic gland mucosa lineage using texture and color enhancement imaging Hisanori Utsunomiya, Hiroya Ueyama, Tsutomu Takeda, Shunsuke Nakamura, Yasuko Uemura, Tomoyo Iwano, Momoko Yamamoto, Ryota Uchida, Daiki Abe, Shotaro Oki, Nobuyuki Suzuki, Atsushi Ikeda, Yoichi Akazawa, Kumiko Ueda, Mariko Hojo, Shuko Nojiri, Takashi Yao, DEN Open.2025;[Epub] CrossRef
Prevalence of Gastric Epithelial Tumors in Helicobacter pylori-uninfected Individuals Undergoing a Medical Checkup Eiko Okimoto, Kyoichi Adachi, Yuri Ebisutani, Norihisa Ishimura, Shunji Ishihara Internal Medicine.2024; 63(16): 2251. CrossRef
A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms Fumiaki Ishibashi, Kosuke Okusa, Yoshitaka Tokai, Toshiaki Hirasawa, Tomohiro Kawakami, Kentaro Mochida, Yuka Yanai, Chizu Yokoi, Yuko Hayashi, Shun-ichiro Ozawa, Koji Uraushihara, Yohei Minato, Hiroyuki Nakanishi, Hiroya Ueyama, Mikinori Kataoka, Yuzo To Gastric Cancer.2024; 27(5): 1078. CrossRef
Improving the quality of the esophagogastroduodenoscopy in Helicobacter pylori-naïve gastric cancer Jae Myung Park Clinical Endoscopy.2023; 56(4): 453. CrossRef
Esophagogastroduodenoscopy (EGD) has been used to diagnose a wide variety of upper gastrointestinal diseases. In particular, EGD is used to screen high-risk subjects of gastric cancer. Quality control of EGD is important because the diagnostic rate is examiner-dependent. However, there is still no representative quality indicator that can be uniformly applied in EGD. There has been growing awareness of the importance of quality control in improving EGD performance. Therefore, we aimed to review the available and emerging quality indicators for diagnostic EGD.
Citations
Citations to this article as recorded by
Endoscopic Submucosal Dissection of Gastric High-Grade Foveolar Dysplasia With Normal Background Mucosa Gonzalo Latorre, Alberto Espino, Christine E. Orr, Robert Bechara Gastro Hep Advances.2025; 4(2): 100565. CrossRef
GastroHUN an Endoscopy Dataset of Complete Systematic Screening Protocol for the Stomach Diego Bravo, Juan Frias, Felipe Vera, Juan Trejos, Carlos Martínez, Martín Gómez, Fabio González, Eduardo Romero Scientific Data.2025;[Epub] CrossRef
Helicobacter pylori-related serum indicators: Cutting-edge advances to enhance the efficacy of gastric cancer screening Hao-Tian Sun World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef
Operation sequence of bidirectional endoscopy with topical anesthesia affected colonoscopy performance: a randomized controlled trial Qing Wang, Yue Sui, Jingwen Gong, Xing Chen BMC Gastroenterology.2025;[Epub] CrossRef
Advancing Upper Gastrointestinal Cancer Detection: A Single-Center Pilot Study Exploring the Potential of Electrical Impedance Spectroscopy in Endoscopic Procedures Hadi Mokhtari Dowlatabad, Reihane Mahdavi, Seyed Rouhollah Miri, Mohammad Reza Fattahi, Hossein Ataee, Narges Yousefpour, Navid Manoochehri, Reza Taslimi, Mohammad Abdolahad Digestive Diseases and Sciences.2025;[Epub] CrossRef
Endoscopists and endoscopic assistants’ qualifications, but not their biopsy rates, improve gastric precancerous lesions detection rate Yao Shen, Xiao-Juan Gao, Xiao-Xue Zhang, Jia-Min Zhao, Fei-Fan Hu, Jing-Lue Han, Wen-Ying Tian, Mei Yang, Yun-Fei Wang, Jia-Le Lv, Qiang Zhan, Fang-Mei An World Journal of Gastrointestinal Endoscopy.2025;[Epub] CrossRef
Prevalence and factors associated with organic dyspepsia in older adults with dyspepsia Natchanon Simngam, Kanokporn Pinyopornpanish, Theerach Kulkheereerattana, Kittat Chuaiad, Panuwat Arayakulsakol, Kanokwan Pinyopornpanish Scientific Reports.2025;[Epub] CrossRef
Current status of quality control in screening esophagogastroduodenoscopy and the emerging role of artificial intelligence Lihui Zhang, Liwen Yao, Zihua Lu, Honggang Yu Digestive Endoscopy.2024; 36(1): 5. CrossRef
Simethicone and N-acetyl cysteine in improving mucosal visibility: Towards a “clearer view” during endoscopy Akash Roy, Mahesh K. Goenka Indian Journal of Gastroenterology.2024; 43(5): 863. CrossRef
Relationship between observation time and detection rate of focal lesions in Esophagogastroduodenoscopy: a single-center, retrospective study Li Dong, Xiaodan Zhang, Yuting Xuan, Peiling Xiong, Yumei Ning, Bing Zhang, Fan Wang, Qiu Zhao, Jun Fang BMC Gastroenterology.2024;[Epub] CrossRef
The Effect of Esophagogastroduodenoscopy on Intraocular Pressure Maddalena De Bernardo, Antonella Santonicola, Marco Gioia, Livio Vitiello, Ferdinando Cione, Sergio Pagliarulo, Paola Iovino, Nicola Rosa Journal of Clinical Medicine.2024; 13(5): 1224. CrossRef
The Diagnostic Performance of Linked Color Imaging Compared to White Light Imaging in Endoscopic Diagnosis of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis Jae Gon Lee, In Kyung Yoo, Abdullah Ozgur Yeniova, Sang Pyo Lee Gut and Liver.2024; 18(3): 444. CrossRef
Optimal number of images and 2-year interval affect cancer detection in screening esophagogastroduodenoscopy: An observational study Kazuhiro Ksahiwagi, Toshifumi Yoshida, Kayoko Fukuhara, Rieko Bessho, Hitoshi Ichikawa, Nagamu Inoue, Hiromasa Takaishi, Yasushi Iwao, Takanori Kanai Medicine.2024; 103(26): e38774. CrossRef
Sistema de auditoría automática para la exploración endoscópica del estómago con Inteligencia Artificial – Gastro UNAL: Gastroendoscopy UNit for Automatic Labeling Martín Alonso Gómez Zuleta, Diego Fernando Bravo Higuera, Josué Andre Ruano Balseca, María Jaramillo González, Fabio Augusto González Osorio, Edgar Eduardo Romero Castro Revista colombiana de Gastroenterología.2024; 39(2): 133. CrossRef
Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer Dong Chan Joo, Gwang Ha Kim Gut and Liver.2024; 18(5): 781. CrossRef
Chronic Atrophic Gastritis and Intestinal Metaplasia: A Latin American Perspective Arnoldo Riquelme, Felipe Silva, Diego Reyes, Gonzalo Latorre The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 218. CrossRef
Esophagogastroduodenoscopy Quality Improvement and the Role of Topical Antiperistaltic Agents: A Systematic Review and Meta-Analysis Eoghan Burke, Patricia Harkins, Mayilone Arumugasamy Cureus.2024;[Epub] CrossRef
Endoscopic Imaging for the Diagnosis of Neoplastic and Pre-Neoplastic Conditions of the Stomach Bruno Costa Martins, Renata Nobre Moura, Angelo So Taa Kum, Carolina Ogawa Matsubayashi, Sergio Barbosa Marques, Adriana Vaz Safatle-Ribeiro Cancers.2023; 15(9): 2445. CrossRef
The effect of short-term training about depth predicting score on the diagnostic ability of invasion depth for differentiated early gastric Cancer among non-expert endoscopists Hui Li, Hui Hu, Ping Geng, Panhui Guo, Yuanrong Zhu, Lulu Zeng, Jun Liu, Xiangpeng Hu BMC Medical Education.2023;[Epub] CrossRef
Variation in the rate of detection of minute and small early gastric cancers at diagnostic endoscopy may reflect the performance of individual endoscopists Daisuke Murakami, Masayuki Yamato, Yuji Amano, Takayoshi Nishino, Makoto Arai BMJ Open Gastroenterology.2023; 10(1): e001143. CrossRef
Improving the quality of the esophagogastroduodenoscopy in Helicobacter pylori-naïve gastric cancer Jae Myung Park Clinical Endoscopy.2023; 56(4): 453. CrossRef
Enhancing the Quality of Upper Gastrointestinal Endoscopy: Current Indicators and Future Trends Caesar Ferrari, Micheal Tadros Gastroenterology Insights.2023; 15(1): 1. CrossRef
Antispasmodic Agent Administration Improves Gastric Neoplasm Detection Rates during Esophagogastroduodenoscopy Sang Yoon Kim, Jae Myung Park The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 246. CrossRef
Clinical features of gastric adenoma detected within 3 years after negative screening endoscopy in Korea Hyun Young Kim Gastroenterology Report.2022;[Epub] CrossRef
Background /Aims: While Helicobacter pylori (HP)-negative gastric cancer is frequently reported, little is known about the predictors for detecting HP-negative early gastric cancer (EGC). We aimed to evaluate the predictors for the detection of HP-negative EGC.
Methods We retrospectively reviewed 13,477 consecutive asymptomatic cases where upper endoscopy was performed by nine physicians from April 2017 to March 2019 and analyzed the detection rate of high-risk lesions (HRLs), including EGC, tubular adenoma, and lymphoma, according to the status of HP infection. The observation time was corrected for multiple regression analyses.
Results For all physicians, the average observation time for screening HP-eradicated and -naïve patients was shorter than that for screening HP-positive patients (p<0.05). Multiple regression analyses revealed that the observation time in the three groups was an independent predictor for detecting HRLs in HP-eradicated patients (p=0.03106, 0.01263, and 0.02485, respectively), while experience of endoscopy was an independent predictor for detecting HRLs in HP-naïve patients (p=0.02638).
Conclusions While observation time during screening endoscopy was a quality indicator for detecting HRLs in HP-eradicated patients, experience of endoscopy was a quality indicator for detecting HRLs in HP-naïve patients.
Citations
Citations to this article as recorded by
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideli Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, Manon C.W. Spaander, Jan Bornschein, Tamara Matysiak-Budnik, Georgios Tziatzios, João Santos-Antunes, Miguel Areia, Nicolas Chapelle, Gianluca Esposito, Gloria Fernandez-Esparrach, Lumir Kunovsky, Mónica Ga Endoscopy.2025; 57(05): 504. CrossRef
The Increasing Trend of the Generational Helicobacter pylori‐Naïve Prevalence Among Japanese Individuals Born Between 1925 and 2015: A Systematic Review and Meta‐Regression Analysis Fumiaki Ishibashi, Chikamasa Ichita, Ayaka Takasu, Ran Li, Yasuhiro Hagiwara, Yutaka Matsuyama, Yuichiro Kemmoto, Chika Kusano, Manami Inoue, Nobutake Yamamichi, Hideki Ishikawa, Takuji Gotoda Helicobacter.2025;[Epub] CrossRef
A mathematical simulation model to determine the optimal endoscopic screening strategy for detection of H. pylori-naïve gastric neoplasms Fumiaki Ishibashi, Kosuke Okusa, Yoshitaka Tokai, Toshiaki Hirasawa, Tomohiro Kawakami, Kentaro Mochida, Yuka Yanai, Chizu Yokoi, Yuko Hayashi, Shun-ichiro Ozawa, Koji Uraushihara, Yohei Minato, Hiroyuki Nakanishi, Hiroya Ueyama, Mikinori Kataoka, Yuzo To Gastric Cancer.2024; 27(5): 1078. CrossRef
Exploring quality indicators for the detection of Helicobacter pylori-naïve gastric cancer: a cross-sectional nationwide survey Fumiaki Ishibashi, Toshiaki Hirasawa, Hiroya Ueyama, Yohei Minato, Sho Suzuki Clinical Endoscopy.2023; 56(4): 460. CrossRef
A Close Follow-Up Strategy in the Short Period of Time after Helicobacter pylori Eradication Contributes to Earlier Detection of Gastric Cancer Fumiaki Ishibashi, Sho Suzuki, Mizuki Nagai, Kentaro Mochida, Konomi Kobayashi, Tetsuo Morishita Digestion.2023; 104(3): 165. CrossRef
Endoscopic diagnosis of early gastric cancer Dong Chan Joo, Gwang Ha Kim Journal of the Korean Medical Association.2022; 65(5): 267. CrossRef
Risk factors for early gastric cancer: focus on Helicobacter pylori gastritis Hee Seok Moon Journal of the Korean Medical Association.2022; 65(5): 259. CrossRef
Tailored eradication strategy vs concomitant therapy for Helicobacter pylori eradication treatment in Korean patients Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo, Dong Kyun Park World Journal of Gastroenterology.2021; 27(31): 5247. CrossRef
Quality management system for screening esophagogastroduodenoscopy improves detection of Helicobacter pylori-negative interval gastric cancer Fumiaki Ishibashi, Konomi Kobayashi, Tomohiro Kawakami, Ryu Tanaka, Kazuaki Sugihara, Satoshi Baba Endoscopy International Open.2021; 09(12): E1900. CrossRef
Quality Indicator for Gastric Cancer Detection Based on Helicobacter pylori Status Jae Myung Park Clinical Endoscopy.2020; 53(6): 629. CrossRef
The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators.In response, several gastrointestinal societies have established quality indicators specific to Barrett’s esophagus, which serve to createthresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistentlydemonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy andobtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovativeinterventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett’s esophagus.
Citations
Citations to this article as recorded by
Endoskopische Diagnostik und Therapie des Ösophaguskarzinoms Alanna Ebigbo, Andreas Probst, Helmut Messmann Die Onkologie.2025; 31(2): 143. CrossRef
Measuring and improving quality in esophageal care and swallowing disorders Alexander T Reddy, Joshua P Lee, David A Leiman Diseases of the Esophagus.2024;[Epub] CrossRef
Impact of Residing in Below Median Household Income Districts on Outcomes in Patients with Advanced Barrett’s Esophagus Suqing Li, Yusuke Fujiyoshi, Sechiv Jugnundan, Gary May, Norman Marcon, Jeffrey Mosko, Christopher Teshima Journal of the Canadian Association of Gastroenterology.2023; 6(4): 137. CrossRef
Clinical variation in surveillance and management of Barrett’s esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons Jamielyn DC Cruz, David Paculdo, Divya Ganesan, Meredith Baker, Rebecca J Critchley-Thorne, Nicholas J Shaheen, Sachin Wani, John W Peabody Medicine.2022; 101(51): e32187. CrossRef
Risk Factors for Self-Expandable Metal Stent Complications in the Treatment of Esophageal Cancer: A Scoping Review Connor K. Wilson, Sara R. Frankowski, Susan C. Steelman, Issam Makhoul SN Comprehensive Clinical Medicine.2020; 2(8): 1163. CrossRef